Introduction
reported the dramatic effect of frusemide (Lasix) in relieving the symptoms in a 65-year-old patient critically ill with acute pulmonary oedema many hours before the onset of diuresis. They suggested that frus de first caused fluid to be removed from the pulmonary circulation and then produced a diuresis. To test this hypothesis the effect of intravenous frusemide on the pulmonary blood volume was studied in seven patients recovering from high-altitude pulmonary oedema. These patients were chosen because previous studies (Roy et al., 1965b (Roy et al., , 1965c had shown that their pulmonary blood volume generally remained increased for 3 to 24 weeks after they had been evacuated to the plains and their symptoms relieved.
Subjects and Methods
Studies were made on seven men aged 24 to 29 years, three to eight weeks after recovery from pulmonary oedema. Before cardiac catheterization they were all asymptomatic and had normal physical findings, electrocardiograms, and chest radiographs.
The patients were studied in the fasting state without sedation. Right heart catheterization was performed by positioning a No. 7 cardiac catheter in the pulmonary artery just beyond the valve. The left atrium was entered by the percutaneous transseptal Brockenbrough method (Brockenbrough and Braunwald, 1960) as practised in our laboratory (Roy et at., 1963) . The right femoral artery was cannulated to obtain arterial blood pressure and dye curves. Consecutive dyedilution curves were obtained direct on a Polyviso channel through a continuous recording densitometer (Colson) by injecting 2 5 mg. of indocyanine green dye into the main pulmonary artery and then into the left atrium. The difference in the mean transit times of the two resulting curves was taken as the pulmonary transit time. The cardiac output was measured from the dilution curves by the formula of Hamilton et al. (1932) (Roy et al., 1965a) . The total blood volume was determined by the Evans blue dye method (Gibson and Evans, 1937) .
The intracardiac and femoral artery pressures were recorded through P23AA strain gauge manometers on a four-channel single-gun photographic system. The baseline for all pressure measurements was taken as being half the chest thickness at the second costal cartilage when the patient was lying supine (Roy et al., 1957) . After obtaining the control data, 40 mg.
of frusemide was injected into the pulmonary artery. Pressures in the pulmonary artery, left atrium, and femoral artery we intermittently recorded for the next 15 minutes, and then a second set of cardiac output, pulmonary blood volume, and pressure measurements was obtained (see Table) .
Results
The pulmonary blood volume, compared with our normal values (range 145 to 310, average 210 ml./sq. m.), was found to be significantly increased in two men (Cases 5 and 6) and was high normal in three others (Cases 1, 3, and 7). The central blood volume was within the normal range. Intracardiac frusemide caused an average fall in the pulmonary blood volume by 23% and in the cardiac output by 33%, but a decrease in central blood volume-in only six subjects-by an average of 11%. The total blood volume, which was measured in only two men (Cases 6 and 7), had decreased significantly in both. Furthermore, the heart rate and the femoral and pulmonary artery pressures did not change after giving frusemide; but, whereas the filling pressures and work index of both ventricles decreased, the pulmonary and systemic vascular resistances increased.
Discussion
The finding that intracardiac frusemide decreased the pulmonary blood volume within 15 minutes of administration and before the onset of diuresis in the seven patients reported above supports the hypothesis of Biagi and Bapat (1967) . Similarly it also explains in part the haemodynamic basis for the clkical improvement which also sometimes occurs. Nevertheless, the percentage reduction of the pulmonary blood volume mi the present study could not be related to the changes seen e r in the central blood volume or in the cardiac output. As similar data on the acute response of the pulmonary blood volume to intravenous frusemide are not available comparisons cannot be made. In a previous study with intravenous morphine, however, the 26% decrease in the pulmonary blood volume value could also not be related to the 19% decrease in the central blood volume or to the 15% decrease in cardiac output (Roy et al., 1965c) . In addition, Samet and Bernstein (1968) , using intravenous ethacrynic acid in 27 subjects, reported that the pulmonary blood volume decreased by 12% and the cardiac output by 20%.
The events following the circulatory response to intravenous frusemide were probably initiated by a reduction in the totl plasma volume, a decrease in the venous retun, a fall in the ventricular filling pressures, and a decrease in cardiac output. in another similar study in progress at present the average fall in the total blood volume value in eight patients was 20%. Furthermore, the total blood volume of five patients with congestive cardiac failure fell by 210% following the administration of 100 mg. of intravenous frusemide (Davidov, Kakaviatos, and Finnerty, 1967) . In the present study it may therefore be surmised that the total blood volume might also have fallen in the other five cases. If reduction in total blood volume initiates circulatory changes the role of the pulmonary blood volume in the chain of events has to be ascertained. The discrepancy between the reduction in the levels in the pulmonary and central blood volumes by frusemide supports our previous observation that the response of the pulmonary blood volume to high-altitude hypoxia was independent of the central blood volume (Roy et al., 1967) . This may represent a form of homoeostasis between the pulmonary and the extrapulmonary blood volumes.
INTRODUCTION
Increasing evidence supports the belief that abnormal aromatic amino-acids and catechol metabolism may be responsible for the manifestations of Parkinson's disease. Interest has centred chiefly on the role of dihydroxyphenylalanine, which is the precursor of both melanin (decreased in the substantia nigra of patients with Parkinsonism) and dopamine (found in reduced quantities in the substantia nigra and the corrus striatum of
